Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Spero Therapeutics (United States) | Researchclopedia

Back to institutions

Spero Therapeutics (United States)

Cambridge, Massachusettscompany

174

Works

14,116

Citations

70

h-index

Top Research Topics

Antibiotic Resistance in Bacteria Antibiotics Pharmacokinetics and Efficacy Urinary Tract Infections Management

Top Researchers

Paul B. Eckburg Spero Therapeutics (United States)

66 works17,901 citationsh-index: 27

Recent Research

Abstract B010: Common translational challenges in brain tumour therapeutic development identified through a multidisciplinary accelerator programme

Eloise Lines,Charlotte Aitken,et al.

20260 citations

Tuberculosis Research and Epidemiology

Pediatric Urology and Nephrology Studies

Mycobacterium research and diagnosis

Antibiotic Use and Resistance

Bacterial Identification and Susceptibility Testing

Fibroblast Growth Factor Research

Liver Disease Diagnosis and Treatment

Pharmaceutical and Antibiotic Environmental Impacts

Drug Transport and Resistance Mechanisms

Donglu Shi University of Cincinnati

551 works16,298 citationsh-index: 68

Thomas Parr University of Oxford

275 works11,409 citationsh-index: 61

Andrew Cheng Spero Therapeutics (United States)

120 works11,065 citationsh-index: 55

Kim E. Barrett Harvard University

468 works10,453 citationsh-index: 55

66 works10,001 citationsh-index: 35

Randomized study of the efficacy, safety, and pharmacokinetics of SPR720 for the treatment of Mycobacterium avium complex pulmonary disease

Xilla T. Ussery,Nivedita Bhatt,et al.

20260 citations

Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysis

Caroline J. Duncombe,Dianna Hergott,et al.

20261 citations

173. Oral Tebipenem Pivoxil Hydrobromide versus Intravenous Imipenem-Cilastatin in Patients with Complicated Urinary Tract Infections or Acute Pyelonephritis: Efficacy and Safety Results from the Phase 3 PIVOT-PO study

David K. Hong,Sibel Ascioglu,et al.

20260 citations

The Federal Tort Claims Act Meets The Supremacy Clause: <i>Martin v. United States</i>

Christopher Mills,Cameron Cox

20260 citations

P-1214. In Vitro Antibacterial Spectrum and Activity of Tebipenem Against Enterobacterales Clinical Isolates Causing Urinary Tract and Bloodstream Infections in the United States and United Kingdom in 2023-2024

Renuka Kapoor,Timothy Doyle,et al.

20260 citations